Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

TSCAN THERAPEUTICS, INC. (TCRX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

TSCAN THERAPEUTICS, INC. (TCRX), most recent 12 months reported: revenue $7.11M, net loss $117.71M, free cash flow -$118.44M. Latest balance sheet on file: liquid cash $100.16M, total debt $32.78M, net cash $67.38M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): ELUTIA INC. · Surrozen, Inc./DE · Relay Therapeutics, Inc. · Caribou Biosciences, Inc. · ZEO SCIENTIFIX, INC · FATE THERAPEUTICS INC · CG Oncology, Inc. · Taysha Gene Therapies, Inc.

Stock screener

Watchlist